Literature DB >> 20129168

Current approaches to the diagnosis and management of paediatric migraine.

Andrew D Hershey1.   

Abstract

Headache is a common complaint in childhood with up to 75% of children reporting a notable headache by the age of 15 years. Paediatric migraine is the most frequent recurrent headache, occurring in up to 28% of older teenagers. Migraine can have a substantial effect on the life of the child, as well as their family, leading to lost school days and withdrawal from social interactions. Early recognition can lead to successful treatment, improved outcome, and reduced disability. The treatment strategy needs to be multipronged and can include acute therapy (which can vary depending on the severity of the headache), preventive therapy (when the headaches are frequent or causing substantial disability), and biobehavioural therapy (to assist with coping with recurrent headaches). Additional factors can contribute to exacerbations of headaches, including comorbid disorders and pubertal changes, which might lead to the development of menstrual migraine. When all these factors are effectively managed, there should be an improvement in long-term outcome and prevention of disease progression. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20129168     DOI: 10.1016/S1474-4422(09)70303-5

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  43 in total

Review 1.  New Developments in the Prophylactic Drug Treatment of Pediatric Migraine: What Is New in 2017 and Where Does It Leave Us?

Authors:  Joanne Kacperski; Allyson Bazarsky
Journal:  Curr Pain Headache Rep       Date:  2017-08

2.  Digital Therapeutic Self-Management Intervention in Adolescents With Migraine: Feasibility and Preliminary Efficacy of "Migraine Manager".

Authors:  Kevin A Hommel; Julia Carmody; Andrew D Hershey; Christina Holbein; Marielle Kabbouche-Samaha; James Peugh; Scott Powers
Journal:  Headache       Date:  2020-04-22       Impact factor: 5.887

3.  Adherence to Biobehavioral Recommendations in Pediatric Migraine as Measured by Electronic Monitoring: The Adherence in Migraine (AIM) Study.

Authors:  Ashley M Kroon Van Diest; Rachelle Ramsey; Brandon Aylward; John W Kroner; Stephanie M Sullivan; Katie Nause; Janelle R Allen; Leigh A Chamberlin; Shalonda Slater; Kevin Hommel; Susan L LeCates; Marielle A Kabbouche; Hope L O'Brien; Joanne Kacperski; Andrew D Hershey; Scott W Powers
Journal:  Headache       Date:  2016-05-11       Impact factor: 5.887

Review 4.  Headache and ADHD in Pediatric Age: Possible Physiopathological Links.

Authors:  Maria Chiara Paolino; Alessandro Ferretti; Maria Pia Villa; Pasquale Parisi
Journal:  Curr Pain Headache Rep       Date:  2015-07

Review 5.  Preventive drugs in childhood and adolescent migraine.

Authors:  Joanne Kacperski; Andrew D Hershey
Journal:  Curr Pain Headache Rep       Date:  2014-06

Review 6.  Migraine treatment in developmental age: guidelines update.

Authors:  Laura Papetti; Alberto Spalice; Francesco Nicita; Maria Chiara Paolino; Rosa Castaldo; Paola Iannetti; Maria Pia Villa; Pasquale Parisi
Journal:  J Headache Pain       Date:  2010-03-27       Impact factor: 7.277

Review 7.  From 0° to 18°: how headache changes over time.

Authors:  Vincenzo Guidetti; Noemi Faedda
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 8.  Perimenstrual headache in adolescence.

Authors:  Andrew D Hershey
Journal:  Curr Pain Headache Rep       Date:  2012-10

9.  Differences in Pediatric Headache Prescription Patterns by Diagnosis.

Authors:  Jonathan Rabner; Allison Ludwick; Alyssa LeBel
Journal:  Paediatr Drugs       Date:  2018-06       Impact factor: 3.022

10.  Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial.

Authors:  Scott W Powers; Susmita M Kashikar-Zuck; Janelle R Allen; Susan L LeCates; Shalonda K Slater; Marium Zafar; Marielle A Kabbouche; Hope L O'Brien; Chad E Shenk; Joseph R Rausch; Andrew D Hershey
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.